α-Tocopherol protects the peroxidative modification of LDL to be recognized by LDL receptors

Journal of Nutritional Science and Vitaminology

Volumn 44, Issue 5, 1998, Pages 697-703

  Sakuma, Nagahiko ^a   Yosikawa, Masae ^a   Hibino, Takeshi ^a   Okada, Masami ^a   Jinno, Yasunari ^a   Tamai, Nozomu ^a   Sasai, Kanna ^a   Yoshimata, Takayuki ^a   Kunimatsu, Mitoshi ^a   Fujinami, Takao ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

LDL receptor; Peroxidized LDL; Tocopherol

Indexed keywords

ALPHA TOCOPHEROL; CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LOW DENSITY LIPOPROTEIN RECEPTOR; PRAVASTATIN;

ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CATALYSIS; CELL CULTURE; CHOLESTEROL BLOOD LEVEL; DATA ANALYSIS; DNA SYNTHESIS; ISCHEMIC HEART DISEASE; LIPID PEROXIDATION;

EID: 0032413544     PISSN: 03014800     EISSN: 18817742     Source Type: Journal    
DOI: 10.3177/jnsv.44.697     Document Type: Article

References (35)

1. Brown MS, Goldstein JL. 1986. A receptor-mediated pathway for cholesterol homeostasis. Science 232: 34-47.
2. Esterbauer H, Rotheneder MD, Waeg G, Striegel G, Jurgen G. 1990. Biochemical, structural, and functional properties of oxidized low-density lipoprotein. Chem Res Toxicol 3: 78-92.
3. Rimm EB, Stampfer MJ, Ascherio A, Giovannucci E, Colditz GA, Willett WC. 1993. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 328: 1450-1456.
4. Stampfer MJ, Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. 1993. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 328: 1444-1449.
5. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. 1989. Beyond cholesterol - Modification of low-density lipoprotein that increase its atherogenicity. N Engl J Med 320: 915-924.
6. Esterbauer H, Gebicki J, Puhl H, Jurgens G. 1992. The role of lipid peroxidation and antioxidants in oxidative modification of LDL. Free Radic Biol Med 13: 341-390.
7. Witztun JL, Steinberg D. 1991. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88: 1785-1792.
8. Haberland ME, Fogelman AM, Edwards PA. 1982. Specificity of receptor-mediated recognition of malondialdehyde-modified low density lipoprotein. Proc Natl Acad Sci USA 79: 1712.
9. Henriksen T, Mahoney EM, Steingerg D. 1981. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells. Recognition by receptors for acetylated low density lipoproteins. Proc Natl Acad Sci USA 78: 6499-6503.
10. Henriksen T, Mahoney EM, Steingerg D. 1983. Enhanced macrophage degradation of biologically modified low density lipoprotein. Arteriosclerosis 3: 149-159.
11. Suzukawa M, Abbey M, Clifton P, Nestel PJ. 1994. Effects of supplementing with vitamin E on the uptake of low density lipoprotein and the stimulation of cholesteryl ester formation in macrophages. Atherosclerosis 110: 77-86.
12. Havel RJ, Eder HA, Bragdon JH. 1955. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34: 1345-1353.
13. Smith PK, Krohn RI, Hermanson GT, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ, Klenk DC. 1985. Measurement of protein using bincinchonic acid. Anal Biochem 150: 76-85.
14. Abe K, Kusabe K, Mukasa K, Ishiguro Y, Sato T, Ishikawa S, Hoshida H. 1984. Determination of vitamin A, E, and K and ubiquinones in plasma by very high speed liquid chromatography. Bunseki Kagaku 33: E309-E314.
15. Ohishi H, Ohkawa H, Miike A, Tatano T, Yagi K. 1985. A new assay method for lipid peroxides using a methylene blue derivative. Biochem Int 10: 201-211.
16. Cuthbert JA, Lipsky PE. 1980. Sterol metabolism and lymphocyte function: Inhibition of endogenous sterol biosynthesis does not prevent mitogen-induced human T lymphocyte activation. J Immunol 124: 2240-2246.
17. Sakuma N, Iwata S, Ichikawa T, Fujinami T. 1992. Assessment of functional low-density-lipoprotein receptors on lymphocytes by simplified method using culture medium with lipoprotein-free fetal calf serum and pravastatin. Clin Biochem 25: 368-370.
18. Iwata S, Sakuma N, Hibino T, Sato T, Yoneyama A, Kamiya Y, Kawaguchi M, Fujinami T, Kunimatsu M. 1995. Influence of anti-LDL receptor antibody on the transfer of cholesterol from LDL isolated lymphocytes in normal subjects. Clin Biochem 28: 309-311.
19. Sakuma N, Iwata S, Ikeuchi R, Ichikawa T, Hibino T, Kamiya Y, Ohte N, Kawaguchi M, Kunimatsu M, Kawahara H, Fujinami T. 1995. Coexisting type III hyperlipoproteinemia and familial hypercholesterolemia: A case report. Metabolism 44: 460-465.
20. Boyum A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand J Clin Lab Invest (Suppl) 21: 77-79.
21. Palinski W, Rosenfeld ME, Yla-Herttula S, Gurtiner GC, Socher SS, Butler SW, Perthasarathy S, Carew TE, Steinberg D, Witztum JL. 1989. Low-density lipoprotein undergoes oxidative modification in vivo. Proc Natl Acad Sci USA 86: 1372-1376.
22. Boyd HC, Gown AM, Wolfbauer G, Chait A. 1989. A direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe-heritable-hyperlipidemic rabbit. Am J Pathol 135: 815-825.
23. Yla-Herttula S, Palinski W, Rosenfeld ME, Perthasarathy S, Carew TE, Butler SW, Witztum JL, Steinberg D. 1989. Evidence for the presence of oxidatively modified LDL in atherosclerotic lesions of rabbit and man. J Clin Invest 84: 1086-1095.
24. Schuh J, Fairclough GF, Haschemeter RH. 1978. Oxygen-mediated heterogeneity of apo-low-density lipoprotein. Proc Natl Acad Sci USA 75: 3173-3177.
25. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. 1984. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci USA 81: 3883-3887.
26. Fong LG, Parthasarathy S, Witztum JL, Steinberg D. 1987. Nonenzymatic oxidative cleavage of peptide bonds in apoprotein B-100. J Lipid Res 28: 1466-1477.
27. Howard JA, Ingold KU. 1967. Absolute rate constants for hydrocarbon autooxidation. VI. Alkyl aromatic and olefinic hydrocarbons. Can J Chem 45: 793-797.
28. Tappel AL. 1962. Vitamin E as the biological lipid antioxidant. Vitam Horm 29: 493-510.
29. Niki E. 1987. Antioxidants in relation to lipid peroxidation. Client Phys Lipids 44: 227-253.
30. Burton GW, Page YL, Gabe EJ, Ingold KU. 1980. Antioxidant activity of vitamin E and related phenols. Importance of stereoelectronic factors. J Am Chem Soc 102: 7791-7792.
31. Burton GW, Ingold KU. 1981. Autoxidation of biological molecules. 1. Antioxidant activity of vitamin E and related chain-breaking phenolic antioxidants in vitro. J Am Chem Soc 103: 6472-6477.
32. Morel DW, DiCorleto PE, Chisolm GM. 1984. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation. Arteriosclerosis 4: 357-364.
33. Hessler JR, Robertson AL Jr, Chisolm GM. 1979. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture. Atherosclerosis 32: 213-229.
34. Stampfer MJ. Hennekens CH, Manson JE, Colditz GA, Rosner B, Willett WC. 1993. Vitamin E consumption and the risk of coronary heart disease in women. N Engl J Med 328: 1444-1449.
35. Gey K, Prska P, Jordan P, Mser U. 1991. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross cultural epidemiology. Am J Clin Nutr 53: 326s-334s.